Author:
Ando Kiyoshi,Maeda Jun,Inaji Motoki,Okauchi Takashi,Obayashi Shigeru,Higuchi Makoto,Suhara Tetsuya,Tanioka Yoshikuni
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Antkiewicz-Michaluk L (2002) Endogenous risk factors in Parkinson’s disease: dopamine and tetrahydroisoquinolines. Pol J Pharmacol 54:567–572
2. Barnes NJ, Bradbury AJ, Costall B, Domeney AM, Kelly ME, Naylor RJ (1986) Neuropharmacological manipulations with MPTP. J Neural Transm Suppl 20:47–63
3. Birkmayer W, Knoll J, Riederer P, Youdim MB, Hars V, Marton J (1985) Increased life expectancy resulting from addition of l-deprenyl to Madopar treatment in Parkinson’s disease: a longterm study. J Neural Transm 64:113–127
4. Doudet D, Gross C, Lebrun-Grandie P, Bioulac B (1986) Effect of increasing regimens of levodopa on chronic MPTP-induced parkinsonism in monkey; mechanographic and electromyographic data. Electromyogr Clin Neurophysiol 26:711–727
5. Gerlach M, Riederer P, Przuntek H, Youdim MB (1991) MPTP mechanisms of neurotoxicity and their implications for Parkinson’s disease. Eur J Pharmacol 208:273–286
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献